Is DHEA-S produced mainly by the adrenal cortex and a circulating precursor for sex hormones?

Dehydroepiandrosterone sulfate (DHEA-S) is an abundant circulating steroid that serves as a vital pre-prohormone reservoir in human physiology. In adult males, it provides a stable, long-term indicator of adrenal endocrine activity and serves as the primary substrate for local, tissue-specific hormone synthesis.

Clinical and Physiological Evidence

• Adrenal Specificity: DHEA-S is synthesized almost exclusively within the zona reticularis of the adrenal cortex. While other androgens have significant gonadal contributions, approximately 95% of circulating DHEA-S in men originates from the adrenal cortex (and 100% in women).
• Clinical Marker Utility: Because of its high circulating concentration, long half-life, and minimal diurnal variation, serum DHEA-S serves as the premier clinical and biochemical marker for assessing adrenal androgen secretory activity. It is routinely used to evaluate conditions like congenital adrenal hyperplasia and virilizing adrenal tumors.
• Systemic Delivery: Circulating DHEA-S acts as an abundant, hydrophilic steroid reservoir that is steadily delivered to diverse peripheral target tissues, including the prostate, skin, adipose tissue, bone, and brain.

Mechanistic Pathways of Conversion

• Adrenal Sulfonation: Within the zona reticularis of the adrenal cortex, the sulfotransferase enzyme SULT2A1 highly catalyzes the PAPS-dependent sulfonation of DHEA into DHEA-S before it is released into the systemic circulation.
• Peripheral Desulfation: Once delivered to target tissues, local steroid sulfatase (STS) enzymes desulfate circulating DHEA-S back into lipophilic DHEA.
• Androgen Synthesis: Following desulfation, locally expressed enzymes—specifically 3β-hydroxysteroid dehydrogenase (3β-HSD) and 17β-hydroxysteroid dehydrogenase (17β-HSD)—sequentially metabolize DHEA into androstenedione and active testosterone. In tissues like the prostate and skin, this is further amplified into dihydrotestosterone (DHT).
• Estrogen Synthesis: Intermediate androgens derived from DHEA-S can also be converted into estrogens. The tissue-specific enzyme aromatase (CYP19A1) converts these substrates into estradiol within target tissues such as adipose tissue, bone, and the brain, regulating local physiological functions independently of systemic gonadal output.

Bottom line

DHEA-S is produced almost exclusively by the adrenal cortex, making it a highly reliable clinical marker of adrenal androgen production. It serves as a circulating precursor reservoir that peripheral target tissues desulfate and convert locally into active male androgens (testosterone, DHT) and estrogens (estradiol) via tissue-specific intracrine enzymes.